Cochrane Abstracts
Transcutaneous carbon dioxide monitoring for the prevention of neonatal morbidity and mortality
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Transcutaneous Carbon Dioxide Monitoring for the Prevention of Neonatal Morbidity and Mortality." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436660/all/Transcutaneous_carbon_dioxide_monitoring_for_the_prevention_of_neonatal_morbidity_and_mortality.
Transcutaneous carbon dioxide monitoring for the prevention of neonatal morbidity and mortality. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436660/all/Transcutaneous_carbon_dioxide_monitoring_for_the_prevention_of_neonatal_morbidity_and_mortality. Accessed March 21, 2025.
Transcutaneous carbon dioxide monitoring for the prevention of neonatal morbidity and mortality. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436660/all/Transcutaneous_carbon_dioxide_monitoring_for_the_prevention_of_neonatal_morbidity_and_mortality
Transcutaneous Carbon Dioxide Monitoring for the Prevention of Neonatal Morbidity and Mortality [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436660/all/Transcutaneous_carbon_dioxide_monitoring_for_the_prevention_of_neonatal_morbidity_and_mortality.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Transcutaneous carbon dioxide monitoring for the prevention of neonatal morbidity and mortality
ID - 436660
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436660/all/Transcutaneous_carbon_dioxide_monitoring_for_the_prevention_of_neonatal_morbidity_and_mortality
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
